% | $
Quotes you view appear here for quick access.

POZEN Inc. Message Board

  • philsie1 philsie1 Nov 29, 2011 3:37 PM Flag

    One overlooked cherry from this deal...

    Part of the deal in selling the rights to Treximet royalties is that it also sold the legal responsibilities in defending those patents. Although POZN already won the first round of patent litigation, all of the generics are appealing. This could have cost POZN another 2-3 mil in litigation costs.

    So in my mind that increases the deals value to about $78 mil.

    Now they are sitting on $110 mil in cash; hopefully investing that. That should mean, conservatively $5mil/yr in returns or better.

    p.s. Despite being so positive long-term, I did sell 1/2 my 25k share position as I had DCA'd quite a bit when we were sitting < $2.50. But I won't close out completely. There may still be some life to this rally, giving it a couple days. If we hold $3 I'm staying in.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
7.80-0.2600(-3.23%)Apr 17 4:00 PMEDT